Home›Stock Screener›Concord Drugs›P/B Ratio

Concord Drugs P/B Ratio

Current P/B Ratio
2.09
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Concord Drugs (CONCORD) P/B ratio is 2.09 (Moderate), book value per share ₹37.69 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. Review CONCORD P/E ratio to evaluate earnings-based valuation against sector peers.

Current Valuation Metrics

P/B Ratio 2.09
Current Price ₹77.45
Book Value/Share ₹37.69
Exchange BSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹49 Cr
Share Capital ₹13 Cr
Reserves & Surplus ₹35 Cr
Outstanding Shares 13,000,000
Book Value per Share ₹37.69

Valuation Signal

Signal Fairly Valued
Historical Avg 1.66
Historical Range 1.05 - 2.43
Percentile 80.0%

Sector Context

Sector Average -0.33
Sector Median 0.6
Sector Rank #11 of 50
Sector Percentile 22.0%

CONCORD P/B Ratio — Valuation Insights & Book Value Analysis

Concord Drugs price-to-book ratio interpretation, valuation status and historical context — current P/B 2.09 (Moderate). For live price, earnings yield and the full fundamental profile, see Concord Drugs share price screener.

  • Current PB is 25.6% above historical average
  • Trading at premium to sector average PB of -0.33

Concord Drugs P/B Ratio Historical Trend

CONCORD annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View Concord Drugs yearly highs lows for the annual high/low range and current price position.

CONCORD Historical P/B Ratio — Book Value Per Share & Year-End Price

Concord Drugs annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 2.05 ₹37.69 ₹77.45 ₹49 Moderate
2025 2.43 ₹34.0 ₹82.48 ₹34 Moderate
2024 1.11 ₹34.0 ₹37.70 ₹34 Moderate
2023 1.68 ₹35.56 ₹59.72 ₹32 Moderate
2022 1.05 ₹31.11 ₹32.55 ₹28 Moderate

CONCORD vs Healthcare Peers — P/B Ratio Comparison

Concord Drugs P/B 2.09 vs Healthcare average -0.33, median 0.6 — range -17.45–1.11.

Sector Average
-0.33
Sector Median
0.6
Lowest P/B
-17.45
Highest P/B
1.11
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.45 ₹21 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Parmax Pharma PARMAX -4.18 ₹29 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.34 ₹75 Low
Krebs Biochemicals & Ind… KREBSBIO -0.88 ₹132 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.56 ₹50 Low